857650-89-6

Basic information

• Product Name: Carbamic acid, [(3S)-1-[[[3-(trifluoromethyl)benzoyl]amino]acetyl]-3-pyrrolidinyl]-, 1,1-dimethylethyl ester (9CI)
• Synonyms: Carbamic acid, [(3S)-1-[[[3-(trifluoromethyl)benzoyl]amino]acetyl]-3-pyrrolidinyl]-, 1,1-dimethylethyl ester (9CI);tert-butyl(S)-(1-((3-(trifluoromethyl)benzoyl)glycyl)pyrrolidin-3-yl)carbamate;EOS-61906;GMEDYAHVPDSLGH-AWEZNQCLSA-N
• CAS NO: 857650-89-6
• Molecular Formula: C₁₉H₂₄F₃N₃O₄
• Molecular Weight: 415.4067696
• EINECS: -0
• Mol File: 857650-89-6.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Carbamic acid, [(3S)-1-[[[3-(trifluoromethyl)benzoyl]amino]acetyl]-3-pyrrolidinyl]-, 1,1-dimethylethyl ester (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(3S)-1-[[[3-(trifluoromethyl)benzoyl]amino]acetyl]-3-pyrrolidinyl]-, 1,1-dimethylethyl ester (9CI)(857650-89-6)
• EPA Substance Registry System: Carbamic acid, [(3S)-1-[[[3-(trifluoromethyl)benzoyl]amino]acetyl]-3-pyrrolidinyl]-, 1,1-dimethylethyl ester (9CI)(857650-89-6)

Safety Data

• Hazardous Substances Data: 857650-89-6(Hazardous Substances Data)

Upstream product

• 17794-48-8 m-trifluoromethylhippuric acid 
• 122536-76-9 3(S)-(tert-butoxycarbonylamino)pyrrolidine 
• 2251-65-2 3-(Trifluoromethyl)benzoyl chloride 

Downstream Products

• 857650-90-9 N-{2-[(3S)-3-aminopyrrolidin-1-yl]-2-oxoethyl}-3-(trifluoromethyl)benzamide 
• 857651-01-5 (S)-N-{2-[3-aminopyrrolidin-1-yl]-2-oxoethyl}-3-(trifluoromethyl)benzamide hydrochloride 

Relevant articles and documents

A METHOD OF TREATING LIVER FIBROSIS

The present invention relates to a method of treating hepatis C and/or liver fibroisis with 3-cycloalkylaminopyrrolidine derivatives of the present invention

Discovery of INCB8761/PF-4136309, a potent, selective, and orally bioavailable CCR2 antagonist

We report the discovery of a new (S)-3-aminopyrrolidine series of CCR2 antagonists. Structure-activity relationship studies on this new series led to the identification of 17 (INCB8761/PF-4136309) that exhibited potent CCR2 antagonistic activity, high sel

3-Cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors

The present invention relates to 3-cycloalkylaminopyrrolidine derivatives of the formula I: (wherein R1, R2, R3, R4, R5, R6, R7, X, Y and Z are as defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of chemokine receptors and more specifically as modulators of the CCR2 and/or CCR5 receptor. The compounds and compositions of the invention may bind to chemokine receptors, e.g., the CCR2 and/or CCR5 chemokine receptors, and are useful for treating diseases associated with chemokine, e.g., CCR2 and/or CCR5, activity, such as atherosclerosis, restenosis, lupus, organ transplant rejection and rheumatoid arthritis.